F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Department of Otolaryngology-Head and Neck Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Otolaryngol Head Neck Surg. 2024 Jul;171(1):11-22. doi: 10.1002/ohn.698. Epub 2024 Feb 28.
Currently, the relationship between parathyroidectomy and objective neuropsychiatric outcomes are not clearly defined. The purpose of this study is to perform the first ever Meta-analysis of preoperative and postoperative PHQ-9 and GAD-7 scores in patients with primary hyperparathyroidism undergoing parathyroidectomy with the goal of identifying a specific psychometric score that could be used as an indication for surgical intervention.
A comprehensive search of the literature was performed using PubMed, Embase, PsycINFO, Web of Science, and Ovid All EBM Reviews.
Studies met inclusion criteria if they evaluated preoperative and postoperative PHQ-9 and/or GAD-7 scores in patients with primary hyperparathyroidism undergoing parathyroidectomy. Random effects Meta-analyses were used to analyze the compiled data.
The literature search returned 1433 articles for initial review of which 6 (1105 participants) met criteria for inclusion and Meta-analysis. Meta-analysis revealed that primary hyperparathyroidism patients had significantly higher presurgical PHQ-9 scores when compared to control groups. Additionally, patients experienced a statistically significant and sustained decrease in PHQ-9 scores following parathyroidectomy. Notably, there was a dramatic decrease in the percentage of patients with PHQ-9 scores ≥10 (considered clinically significant for depression) following parathyroidectomy.
Patients with primary hyperparathyroidism experience a statistically significant and sustained improvement in PHQ-9 scores following parathyroidectomy. Additionally, symptoms of anxiety and suicidal ideation appear to decrease after parathyroidectomy. We propose that a PHQ-9 score ≥10 could potentially be used as an indication for parathyroidectomy in patients with asymptomatic primary hyperparathyroidism.
目前,甲状旁腺切除术与客观神经精神结局之间的关系尚不清楚。本研究的目的是首次对原发性甲状旁腺功能亢进症患者行甲状旁腺切除术前后 PHQ-9 和 GAD-7 评分进行 Meta 分析,旨在确定可作为手术干预指征的特定心理测量评分。
使用 PubMed、Embase、PsycINFO、Web of Science 和 Ovid 所有循证医学评论对文献进行全面检索。
如果评估原发性甲状旁腺功能亢进症患者行甲状旁腺切除术前后 PHQ-9 和/或 GAD-7 评分的研究符合纳入标准,则将其纳入。使用随机效应 Meta 分析对汇总数据进行分析。
文献检索最初共检索到 1433 篇文章,其中 6 篇(1105 名参与者)符合纳入和 Meta 分析标准。Meta 分析显示,原发性甲状旁腺功能亢进症患者的术前 PHQ-9 评分明显高于对照组。此外,患者在甲状旁腺切除术后 PHQ-9 评分显著持续下降。值得注意的是,甲状旁腺切除术后 PHQ-9 评分≥10 的患者比例(被认为与抑郁相关具有临床意义)明显下降。
原发性甲状旁腺功能亢进症患者在甲状旁腺切除术后 PHQ-9 评分有统计学意义的持续改善。此外,焦虑和自杀意念的症状似乎在甲状旁腺切除术后减轻。我们建议,PHQ-9 评分≥10 可能可作为无症状原发性甲状旁腺功能亢进症患者行甲状旁腺切除术的指征。